Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 3—March 2023
CME ACTIVITY - Research

Clonal Expansion of Multidrug-Resistant Streptococcus dysgalactiae Subspecies equisimilis Causing Bacteremia, Japan, 2005–2021

Koh Shinohara, Kazunori Murase, Yasuhiro Tsuchido, Taro Noguchi, Satomi Yukawa, Masaki Yamamoto, Yasufumi Matsumura, Ichiro Nakagawa, and Miki NagaoComments to Author 
Author affiliation: Kyoto University Graduate School of Medicine, Kyoto, Japan

Main Article

Table 2

Clinical manifestations and severity markers for 146 episodes of multidrug-resistant Streptococcus dysgalactiae subspecies equisimilis bacteremia, Japan, 2005–2021*

Characteristics No. (%)
Type of infection
Community-acquired 136 (93.2)
Nosocomial
10 (6.8)
Clinical source of bacteremia†
Cellulitis 74 (50.7)
Primary bacteremia without focus 27 (18.5)
Necrotizing fasciitis 10 (6.8)
Vertebral osteomyelitis and discitis 10 (6.8)
Psoas abscess 6 (4.1)
Septic arthritis 11 (7.5)
Infectious endocarditis 4 (2.7)
Urinary tract infection 7 (4.8)
Pneumonia 1 (0.7)
Others‡
14 (9.6)
Clinical characteristics
Body temperature >38°C, n = 143 100 (69.9)
Mean arterial pressure <80 mm Hg, n = 140 42 (30.0)
Heart rate >90 beats/min, n = 138 83 (60.1)
Disturbance of consciousness, n = 141
54 (38.3)
Severe disease, n = 142
Streptococcus toxic shock syndrome 7 (4.9)
Vasopressor support required 11 (7.7)
Ventilator support required 6 (4.2)
Admission to intensive care unit required
9 (6.3)
Death
In-hospital death, n = 143 10 (7.0)
30-d mortality, n = 138 5 (3.6)

*Data include 13 relapse or reinfection episodes among 9 patients (details are available in Appendix 2 Table 1). †Data include >1 instance per patient, including 3 case-patients with cellulitis and septic arthritis; 2 with vertebral osteomyelitis and psoas abscess; and 1 with each of the following co-infections: cellulitis and vertebral osteomyelitis; cellulitis and psoas abscess; cellulitis and urinary tract infection; necrotizing fasciitis and septic arthritis; vertebral osteomyelitis and septic arthritis; psoas abscess and septic arthritis; infective endocarditis and vertebral osteomyelitis; cellulitis and mycotic aneurysm; vertebral osteomyelitis, psoas abscess, and pyogenic lymphadenitis; vertebral osteomyelitis, psoas abscess, and urinary tract infection; vertebral osteomyelitis, septic arthritis, and empyema. ‡Other infections were 3 cases of catheter-related bloodstream infection; 3 cases of decubitus infection; 2 cases of secondary peritonitis; and 1 case each of empyema; surgical site infection; retroperitoneal abscess; pyogenic lymphadenitis; and mycotic aneurysm.

Main Article

Page created: February 23, 2023
Page updated: February 23, 2023
Page reviewed: February 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external